They appear to be burning about $400k per quarter according to MM.
At the end of June they had about $950k in bank.
My guess and it is no more than a guess is that this next trial would be no more expensive than the last or of a similar order of expense.
I say this because and again I'm guessing trial size will be relaively small.
Don't know that they would test HIV at the moment.
Would not be surprised if on the strength of last trial results a big pharma starts to take a look.
DYOR
great result from biotron, page-13
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.001(2.63%) |
Mkt cap ! $17.59M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.9¢ | $11.54K | 604.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1466986 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 830622 | 7 |
View Market Depth
| Last trade - 15.55pm 15/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |